Peroxisome Proliferator-Activated Receptor γ and Hepatic Stellate Cell Activation

Extracellular Matrix and The Liver: Approach to Gene Therapy

Volumn , Issue , 2003, Pages 179-188

  Miyahara, Takeo ^a,b   Hazra, Saswati ^a,b   Xiong, Shigang ^a,b   Motomura, Kenta ^a,b   She, Hongyun ^a,b   Tsukamoto, Hidekazu ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903540694     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012525251-5/50011-7     Document Type: Chapter

References (33)

1. Buckingham R.E., Al Barazanji K.A., Toseland C.D., Slaughter M., Connor S.C., West A., Bond B., Urner N.C., Clapham J.C. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 1998, 47:1326-1334.
2. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Med. 2001, 7:48-52.
3. Chen Z., Ishibashi S., Perrey S., Osuga J., Gotoda T., Kitamine T., Tamura Y., Okazaki H., Yahagi N., Iizuka Y., Shionoiri F., Ohashi K., Harada K., Shimano H., Nagai R., Yamada N. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL. Arterioscler. Thromb. Vasc. Biol. 2001, 21:372-377.
4. Davis B.H., Kramer R.T., Davidson N.O. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J. Clin. Invest. 1990, 86:2062-2070.
5. elSisi A.E., Hall P., Sim W.L., Earnest D.L., Sipes I.G. Characterization of vitamin A potentiation of carbon tetrachloride-induced liver injury. Toxicol. Appl. Pharmacol. 1993, 119:280-288.
6. Friedman S.L., Wei S., Blaner W.S. Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-conditioned medium and PDGF. Am. J. Physiol. 1993, 264:G947-G952.
7. Galli A., Crabb D., Price D., Ceni E., Salzano R., Surrenti C., Casini A. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000, 31:101-108.
8. Galli A., Crabb D.W., Ceni E., Salzano R., Mello T., Svegliati-Baroni G., Ridolfi F., Trozzi L., Surrenti C., Casini A. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122:1924-1940.
9. Hellemans K., Grinko I., Rombouts K., Schuppan D., Geerts A. All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut 1999, 45:134-142.
10. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., Witztum J.L., Funk C.D., Conrad D., Glass C.K. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
11. Imai S., Okuno M., Moriwaki H., Muto Y., Murakami K., Shudo K., Suzuki Y., Kojima S. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90. FEBS Lett. 1997, 411:102-106.
12. Jarrous N., Kaempfer R. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 1994, 269:23141-23149.
13. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
14. Juge-Aubry C., Pernin A., Favez T., Burger A.G., Wahli W., Meier C.A., Desvergne B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: Importance of the 5'-flanking region. J. Biol. Chem. 1997, 272:25252-25259.
15. Kawahito Y., Kondo M., Tsubouchi Y., Hashiramoto A., Bishop-Bailey D., Inoue K., Kohno M., Yamada R., Hla T., Sano H. 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 2000, 106:189-197.
16. Lee H.Y., Sueoka N., Hong W.K., Mangelsdorf D.J., Claret F.X., Kurie J.M. All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity. Mol. Cell. Biol. 1999, 19:1973-1980.
17. Leo M.A., Lieber C.S. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology 1983, 3:1-11.
18. Marra F., Efsen E., Romanelli R.G., Caligiuri A., Pastacaldi S., Batignani G., Bonacchi A., Caporale R., Laffi G., Pinzani M.E.A. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000, 119:466-478.
19. Marx N., Schonbeck U., Lazar M.A., Libby P., Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 1998, 83:1097-1103.
20. Miyahara T., Schrum L., Rippe R., Xiong S., Yee H.F., Motomura K., Anania F.A., Willson T.M., Tsukamoto H. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem. 2000, 275:35715-35722.
21. Ohata M., Lin M., Satre M., Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am. J. Physiol. 1997, 272:G589-G596.
22. Okuno M., Moriwaki H., Imai S., Muto Y., Kawada N., Suzuki Y., Kojima S. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology 1997, 26:913-921.
23. Okura T., Nakamura M., Takata Y., Watanabe S., Kitami Y., Hiwada K. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells. Eur. J. Pharmacol. 2000, 407:227-235.
24. Potter J.J., Womack L., Mezey E., Anania F.A. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem. Biophys. Res. Commun. 1998, 244:178-182.
25. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
26. Seifert W.F., Bosma A., Brouwer A., Hendriks H.F., Roholl P.J., van Leeuwen R.E., van Thiel-de Ruiter G.C., Seifert-Bock I., Knook D.L. Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats. Hepatology 1994, 19:193-201.
27. Senoo H., Wake K. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab. Invest. 1985, 52:182-194.
28. Spiegelman B.M., Flier J.S. Adipogenesis and obesity: Rounding out the big picture. Cell 1996, 87:377-389.
29. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
30. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
31. Tsukamoto H., Cheng S., Blaner W.S. Effects of dietary polyunsaturated fat on ethanol-induced Ito cell activation. Am. J. Physiol. 1996, 270:G581-G586.
32. Xiong S., Miyahara T., Schrum L., Rippe R., Yee H.F., Yavrom S.M., She H., Willson T.M., Tsukamoto H. PPAR-gamma inhibits hepatic stellate cell collagen gene expression. Hepatology 2000, 32:89. [Abstract].
33. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B.M., Moller D.E. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol. Endocrinol. 1996, 10:1457-1466.